Read More Analyst Ratings News Price Target Upgrades Goldman Sachs Upgrades Horizon Therapeutics to Buy, Announces $168 Price Target By Benzinga Newsdesk Today, 7:15 AM Goldman Sachs analyst Madhu Kumar upgrades Horizon Therapeutics (NASDAQ:HZNP) from Neutral to Buy and announces $168 price target. HZNP
Read More Cannabis Earnings M&A Markets News Penny Stocks KushCo Holdings Announces Q3 2021 Preliminary Results Ahead Of Merger With Greenlane By Jelena Martinovic Today, 7:15 AM KushCo Holdings, Inc. (OTCQX: KSHB) expects that its preliminary and unaudited fiscal third quarter 2021 revenue will range between $27.5 million and $28 million, representing an increase between 21% and 26% on a year-over-year basis. GNLN
Read More News Tesla Becomes First $100B Public Car Company in Extended Trading Tuesday By Charles Gross Today, 7:15 AM -Reuters https://www.reuters.com/article/us-tesla-stocks/tesla-crosses-100-billion-stock-market-valuation-in-extended-trading-idUSKBN1ZL046 TSLA
Read More Analyst Ratings News Price Target Wells Fargo Maintains Equal-Weight on RLJ Lodging, Lowers Price Target to $13.5 By Benzinga Newsdesk Today, 7:15 AM Wells Fargo analyst Dori Kesten maintains RLJ Lodging (NYSE:RLJ) with a Equal-Weight and lowers the price target from $15 to $13.5. RLJ